FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161987148> ?p ?o ?g. }

• W2161987148 endingPage "216" @default.
• W2161987148 startingPage "209" @default.
• W2161987148 abstract "Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been treated by hormonal therapy. Almost all prostate cancer patients initially respond to hormonal therapy, but the majority gradually develop resistance. The mechanism of the change in tumors from being androgen-responsive to androgen-unresponsive is generally explained by clonal selection, adaptation, an alternative pathway of signal transduction and androgen receptor (AR) involvement. Since androgen action is mediated by ARs, abnormalities in ARs are believed to play an important role in the progression of prostate cancer. Hyperactivated AR gene mutations have been detected in 20-30% of hormone-refractory tumors and functional analyses have demonstrated a wide responsiveness to estrogens, progesterone and anti-androgens as well as to androgens. The AR is highly amplified in 30% of patients with hormone-refractory prostate cancer that has been treated by castration without anti-androgens. Immunohistochemical studies of ARs in hormone-refractory prostate cancer specimens have shown that AR protein is down-regulated. DNA hypermethylation of the AR promoter region leading to AR down-regulation has been identified in 30% of hormone-refractory prostate cancers. The AR N-terminal domain in the LNCaP cell line model is activated by interleukin-6 via mitogen-activated protein kinase and single transducers and activators of transcription 3. Epidemiological observations have shown that short CAG repeats are more frequently associated with higher transactivational function in the African-American population, which may explain racial differences in the incidence of prostate cancer. Among Japanese, a short CAG repeat appears to predict a response to hormonal therapy, indicating a positive prognostic value and good prognosis at the metastatic stage of prostate cancer. Several co-factors between ARs and the transcriptional complex have been cloned and reports indicate that steroid receptor co-activator 1 is correlated with the hormone-refractory progression of prostate cancer. Thus, ARs plays an important role in the progression of prostate cancer. Based on the findings described above, genetic diagnosis and/or molecular-targeted therapy via AR pathways can be developed for hormone-refractory states." @default.
• W2161987148 created "2016-06-24" @default.
• W2161987148 creator A5022788665 @default.
• W2161987148 creator A5039530102 @default.
• W2161987148 creator A5046362015 @default.
• W2161987148 creator A5051657206 @default.
• W2161987148 date "2003-06-01" @default.
• W2161987148 modified "2023-10-02" @default.
• W2161987148 title "Androgen receptor involvement in the progression of prostate cancer." @default.
• W2161987148 cites W1489915607 @default.
• W2161987148 cites W1552528612 @default.
• W2161987148 cites W1580523172 @default.
• W2161987148 cites W1948931726 @default.
• W2161987148 cites W1969241521 @default.
• W2161987148 cites W1981647649 @default.
• W2161987148 cites W1984539870 @default.
• W2161987148 cites W1997058929 @default.
• W2161987148 cites W2009269691 @default.
• W2161987148 cites W2022635468 @default.
• W2161987148 cites W2046048837 @default.
• W2161987148 cites W2060181878 @default.
• W2161987148 cites W2066570340 @default.
• W2161987148 cites W2066992571 @default.
• W2161987148 cites W2102892939 @default.
• W2161987148 cites W2113249646 @default.
• W2161987148 cites W2117325725 @default.
• W2161987148 cites W2125957951 @default.
• W2161987148 cites W2139816703 @default.
• W2161987148 cites W2340799873 @default.
• W2161987148 cites W2036744671 @default.
• W2161987148 doi "https://doi.org/10.1677/erc.0.0100209" @default.
• W2161987148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12790784" @default.
• W2161987148 hasPublicationYear "2003" @default.
• W2161987148 type Work @default.
• W2161987148 sameAs 2161987148 @default.
• W2161987148 citedByCount "155" @default.
• W2161987148 countsByYear W21619871482012 @default.
• W2161987148 countsByYear W21619871482013 @default.
• W2161987148 countsByYear W21619871482014 @default.
• W2161987148 countsByYear W21619871482015 @default.
• W2161987148 countsByYear W21619871482016 @default.
• W2161987148 countsByYear W21619871482017 @default.
• W2161987148 countsByYear W21619871482018 @default.
• W2161987148 countsByYear W21619871482019 @default.
• W2161987148 countsByYear W21619871482020 @default.
• W2161987148 countsByYear W21619871482021 @default.
• W2161987148 countsByYear W21619871482022 @default.
• W2161987148 countsByYear W21619871482023 @default.
• W2161987148 crossrefType "journal-article" @default.
• W2161987148 hasAuthorship W2161987148A5022788665 @default.
• W2161987148 hasAuthorship W2161987148A5039530102 @default.
• W2161987148 hasAuthorship W2161987148A5046362015 @default.
• W2161987148 hasAuthorship W2161987148A5051657206 @default.
• W2161987148 hasBestOaLocation W21619871481 @default.
• W2161987148 hasConcept C121608353 @default.
• W2161987148 hasConcept C126322002 @default.
• W2161987148 hasConcept C134018914 @default.
• W2161987148 hasConcept C2776235491 @default.
• W2161987148 hasConcept C2777911890 @default.
• W2161987148 hasConcept C2779723316 @default.
• W2161987148 hasConcept C2780192828 @default.
• W2161987148 hasConcept C2908647359 @default.
• W2161987148 hasConcept C502942594 @default.
• W2161987148 hasConcept C61367390 @default.
• W2161987148 hasConcept C71315377 @default.
• W2161987148 hasConcept C71924100 @default.
• W2161987148 hasConcept C86803240 @default.
• W2161987148 hasConcept C99454951 @default.
• W2161987148 hasConceptScore W2161987148C121608353 @default.
• W2161987148 hasConceptScore W2161987148C126322002 @default.
• W2161987148 hasConceptScore W2161987148C134018914 @default.
• W2161987148 hasConceptScore W2161987148C2776235491 @default.
• W2161987148 hasConceptScore W2161987148C2777911890 @default.
• W2161987148 hasConceptScore W2161987148C2779723316 @default.
• W2161987148 hasConceptScore W2161987148C2780192828 @default.
• W2161987148 hasConceptScore W2161987148C2908647359 @default.
• W2161987148 hasConceptScore W2161987148C502942594 @default.
• W2161987148 hasConceptScore W2161987148C61367390 @default.
• W2161987148 hasConceptScore W2161987148C71315377 @default.
• W2161987148 hasConceptScore W2161987148C71924100 @default.
• W2161987148 hasConceptScore W2161987148C86803240 @default.
• W2161987148 hasConceptScore W2161987148C99454951 @default.
• W2161987148 hasLocation W21619871481 @default.
• W2161987148 hasLocation W21619871482 @default.
• W2161987148 hasOpenAccess W2161987148 @default.
• W2161987148 hasPrimaryLocation W21619871481 @default.
• W2161987148 hasRelatedWork W1970062306 @default.
• W2161987148 hasRelatedWork W2004261902 @default.
• W2161987148 hasRelatedWork W2027181664 @default.
• W2161987148 hasRelatedWork W2081963757 @default.
• W2161987148 hasRelatedWork W2082788526 @default.
• W2161987148 hasRelatedWork W2103250319 @default.
• W2161987148 hasRelatedWork W2104364640 @default.
• W2161987148 hasRelatedWork W2112104987 @default.
• W2161987148 hasRelatedWork W2541857854 @default.
• W2161987148 hasRelatedWork W2772229485 @default.
• W2161987148 isParatext "false" @default.
• W2161987148 isRetracted "false" @default.

• next